Document is current
Any future updates will be listed below
-
Authors
Malaspina, Patrizia
Jodice, Carla
Ciminelli, Bianca Maria
Biancolella, Michela
Colona, Vito Luigi
Latini, Andrea
Leonardis, Francesca
Rogliani, Paola
Novelli, Antonio
Novelli, Giuseppe
Novelletto, Andrea
-
Funding
Funding for this research was provided by:
HORIZON EUROPE European Research Council (HORIZON-HLTH-2021-DISEASE-04 PROGRAM UNDER GRANT AGREEMENT N. 101057100 (UNDINE))
- License Information
-
More Information
Article History
Received: 24 October 2024
Accepted: 17 January 2025
First Online: 30 January 2025
Declarations
:
: Biological samples used in this study were collected according to the ethical procedures of the GEFACOVID2.0 research program active to the Tor Vergata Hospital. This program ensures that the work is carried out with the highest regard for ethical issues and concerning the rights, integrity, and privacy of patients. All consent, material/information storage, and distribution procedures have been approved by the local Ethics Committees (CEI PTV protocol no. 50/20). SARS‐CoV‐2 positive patients who are offered participation in a research study sign an informed consent prepared ad hoc, which provides detailed information on the type of test, the implications of the genetic results, and the possible psychosocial implications.
: The authors declare no competing interests.
